- $1.43bn
- $729.72m
- $0.52m
- 48
- 13
- 55
- 32
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.06 | ||
| Price to Tang. Book | 2.06 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2,752.53 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -25.61% | ||
| Return on Equity | -29.08% | ||
| Operating Margin | -34296.74% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 16.98 | 44.95 | 19.79 | 70.81 | 0.52 | 0.25 | 0.33 | -31.11% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Morphic Holding, Inc. is a biopharmaceutical company. The Company is engaged in discovering and developing a pipeline of potentially oral small molecule integrin therapeutics for the treatment of serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, fibrosis and cancer. The Company’s Morphic integrin technology platform (MInT Platform) helps to develop product candidates designed to achieve the potency, high selectivity and pharmaceutical properties required for oral administration. The Company is advancing its pipeline, including its lead product candidate, MORF-057, an orally administered a4b7-specific integrin inhibitor affecting inflammation, into clinical development for the treatment of inflammatory bowel disease (IBD). It has also developed avb6-specific integrin inhibitors for the treatment of fibrotic diseases including idiopathic pulmonary fibrosis (IPF) and additional indications.
Directors
- Gustav Christensen CHM (73)
- Praveen Tipirneni PRE (52)
- Timothy Springer FDR (72)
- Marc Schegerin CFO
- Robert Farrell SVF (55)
- Bruce Rogers CSO (52)
- William DeVaul GCN (50)
- Norbert Bischofberger IND (65)
- Martin Edwards IND (65)
- Susannah Gray IND (60)
- Nilesh Kumar IND (44)
- Nisha Nanda IND
- Amir Nashat IND (47)
- Joseph Slattery IND (56)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- August 21st, 2014
- Public Since
- June 27th, 2019
- No. of Shareholders
- 14
- No. of Employees
- 121
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
NASDAQ Global Market- Shares in Issue
- 50,037,229
- Address
- 35 GATEHOUSE DRIVE A2, WALTHAM, 02451
- Web
- https://morphictx.com/
- Phone
- +1 7819960955
- Auditors
- Ernst & Young LLP
Upcoming Events for MORF
Morphic Holding Inc Annual Shareholders Meeting
Q2 2024 Morphic Holding Inc Earnings Release
Similar to MORF
89bio
NASDAQ Global Market
Abivax SA
NASDAQ Global Market
AC Immune SA
NASDAQ Global Market
Acrivon Therapeutics
NASDAQ Global Market
Adagene
NASDAQ Global Market
FAQ
What is the Morphic Holding share price?
As of Today at 19:14 UTC, shares in Morphic Holding are trading at $28.66. This share price information is delayed by 15 minutes.
How has the Morphic Holding share price performed this year?
Shares in Morphic Holding last closed at $28.66 and the price had moved by -21.33% over the past 365 days. In terms of relative price strength the Morphic Holding share price has underperformed the S&P500 Index by -36.47% over the past year.
What are the analyst and broker recommendations for Morphic Holding?
The overall consensus recommendation for Morphic Holding is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Morphic Holding dividend yield?
Morphic Holding does not currently pay a dividend.
Does Morphic Holding pay a dividend?
Morphic Holding does not currently pay a dividend.
When does Morphic Holding next pay dividends?
Morphic Holding does not currently pay a dividend.
How do I buy Morphic Holding shares?
To buy shares in Morphic Holding you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Morphic Holding?
As of the previous close price of $28.66, shares in Morphic Holding had a market capitalisation of $1.43bn.
Where are Morphic Holding shares listed?
Here are the trading details for Morphic Holding:
- Country of listing: United States
- Exchange: NMQ
- Ticker Symbol: MORF
What kind of share is Morphic Holding?
Based on an overall assessment of its quality, value and momentum Morphic Holding is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Morphic Holding share price forecast for 2024?
The analyst consensus target price for shares in Morphic Holding is $56.75. That is 98.01% above the last closing price of $28.66.
Analysts covering Morphic Holding currently have a consensus Earnings Per Share (EPS) forecast of -$3.90 for the next financial year.
What is the trend in the Morphic Holding share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Morphic Holding. Over the past six months, its share price has outperformed the S&P500 Index by +13.11%.
As of the last closing price of $28.66, shares in Morphic Holding were trading -21.76% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Morphic Holding PE Ratio?
The Morphic Holding PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $28.66.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Morphic Holding?
Morphic Holding's management team is headed by:
- Gustav Christensen - CHM
- Praveen Tipirneni - PRE
- Timothy Springer - FDR
- Marc Schegerin - CFO
- Robert Farrell - SVF
- Bruce Rogers - CSO
- William DeVaul - GCN
- Norbert Bischofberger - IND
- Martin Edwards - IND
- Susannah Gray - IND
- Nilesh Kumar - IND
- Nisha Nanda - IND
- Amir Nashat - IND
- Joseph Slattery - IND